Capricor Therapeutics (CAPR) Non-Current Assets (2010 - 2026)

Capricor Therapeutics' Non-Current Assets history runs 17 years deep, the most recent figure standing at $43.2 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 474.78% year-over-year to $43.2 million in Q1 2026; TTM through Mar 2026 was $111.1 million, a 278.68% increase from a year earlier, with the FY2025 full-year figure at $33.0 million, up 365.2% from the prior year.
• Non-Current Assets rose to $43.2 million in Q1 2026 per CAPR's latest filing, from $33.0 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $43.2 million in Q1 2026 and bottomed at $5.3 million in Q1 2022.
• The 5-year median for Non-Current Assets is $7.5 million (2025), against an average of $11.9 million.
• Across the five-year window, Non-Current Assets fell 9.94% in 2024 and jumped 474.78% in 2026, its largest moves.
• Year by year, Non-Current Assets stood at $7.2 million in 2022, then advanced by 9.33% to $7.9 million in 2023, then retreated by 9.94% to $7.1 million in 2024, then surged by 365.2% to $33.0 million in 2025, then jumped by 30.86% to $43.2 million in 2026.
• Per Business Quant, the three latest CAPR Non-Current Assets figures stand at $43.2 million (Q1 2026), $33.0 million (Q4 2025), and $25.5 million (Q3 2025).